Continuous glucose monitoring in a healthy population.

A newly published review of the scientific literature. “It is our contention that CGM offers a convenient, minimally-invasive means of improving an individual’s health and wellbeing, and in the future, this technology could be widely available over-the counter, recommended by physicians, and reimbursed by insurance coverage for uses beyond DM.” The researchers work for Abbott, one of the dominant manufacturers in the market. ~ learn more